Georgetown Lombardi, Washington's only NCI-designated Comprehensive Cancer Center, is an approved research consortium with the John Theurer Cancer Center/Hackensack Meridian Health in New Jersey.
$100,000 Matching Gift Expires Dec. 31
Your donation today DOUBLES to advance new discoveries that will lead to cures. And 100% goes directly to research. Make twice the impact in the fight against cancer!
We are developing and testing the cancer treatments of tomorrow - targeted therapies that will improve both survival and quality of life.
Award-winning physicians, state-of-the-art facilities, and a high commitment to excellence—qualities that make Lombardi stand out above the rest!
Educating and training tomorrow's leaders in cancer treatment and research is our mission.
Discover what distinguishes Georgetown Lombardi Comprehensive Cancer Center,
Washington, D.C.’s only National Cancer Institute-designated Comprehensive Cancer Center.
Georgetown University President John J. DeGioia discusses the significance of Georgetown Lombardi's research.
Meet 
Georgetown University Medical Center is an internationally recognized academic health and science center with a four-part mission of research, teaching, service and patient care (provided through a partnership with MedStar Health).
Lombardi News Stories
-
Palbociclib is Safe for Women with Advanced Breast Cancer Who Have Unique Gene Alteration
-
Scientific Presentations at 2019 Ruesch Symposium Inspire
-
Remission of Follicular Lymphoma for Two-Plus Years Indicates Disease-Free Status that Could Be Lifelong
-
Deeper Look at Tumor’s Genetic Mutations Challenges Current Precision Medicine Approach